The NRF2 transcriptional target, OSGIN1, contributes to monomethyl fumarate-mediated cytoprotection in human astrocytes

The NRF2 transcriptional target, OSGIN1, contributes to monomethyl fumarate-mediated cytoprotection in human astrocytes
复制标题

DOI:
10.1038/srep42054
复制
发表时间:
2017-02-09
期刊:
影响因子:
4.6
通讯作者:
Scannevin, Robert H.
Scannevin, Robert H.
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Brennan, Melanie S.;Matos, Maria F.;Scannevin, Robert H.

文献摘要

被引文献

相似文献

富马酸二甲酯(DMF)适用于治疗复发性多发性硬化症,可能通过激活核因子(红细胞衍生2)样2(NRF 2)途径发挥治疗作用。经口DMF给药后,中枢神经系统(CNS)组织主要暴露于富马酸单甲酯(MMF),DMF的生物活性代谢产物,可稳定NRF 2并诱导抗氧化基因表达;然而,由MMF调节的导致细胞保护的详细NRF 2依赖性机制尚不清楚。我们的数据确定了人星形胶质细胞中MMF介导的细胞保护机制,该机制以OSGIN 1依赖性方式发挥作用,特别是通过上调OSGIN 1 -61 kDa亚型。NRF 2依赖性OSGIN 1表达诱导P53核转位后,MMF管理,导致细胞周期抑制和细胞保护氧化的挑战。这项研究提供了在人CNS衍生细胞中通过NRF 2,OSGIN 1和P53对DMF介导的细胞保护作用的机制见解,并有助于我们了解DMF如何在临床上改善神经退行性疾病的病理过程。
Dimethyl fumarate (DMF) is indicated for the treatment of relapsing multiple sclerosis and may exert therapeutic effects via activation of the nuclear factor (erythroid-derived 2)-like 2 (NRF2) pathway. Following oral DMF administration, central nervous system (CNS) tissue is predominantly exposed to monomethyl fumarate (MMF), the bioactive metabolite of DMF, which can stabilize NRF2 and induce antioxidant gene expression; however, the detailed NRF2-dependent mechanisms modulated by MMF that lead to cytoprotection are unknown. Our data identify a mechanism for MMF-mediated cytoprotection in human astrocytes that functions in an OSGIN1-dependent manner, specifically via upregulation of the OSGIN1-61 kDa isoform. NRF2-dependent OSGIN1 expression induced P53 nuclear translocation following MMF administration, leading to cell-cycle inhibition and cell protection against oxidative challenge. This study provides mechanistic insight into MMF-mediated cytoprotection via NRF2, OSGIN1, and P53 in human CNS-derived cells and contributes to our understanding of how DMF may act clinically to ameliorate pathological processes in neurodegenerative disease.